Evaluating Weight Loss Outcomes in Patients With Overweight or Obesity
NCT07551193 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-04-24
Summary
The goal of this observational study is to evaluate weight loss outcomes in adults with overweight or obesity using weight management medications. The main questions it aims to answer are: (1) How much weight do patients lose after 12 months? (2) Do blood sugar and cholesterol levels improve? (3) How safe and tolerable are these medications? This is a retrospective study using existing medical records and pharmacy claims. Participants will not be asked to do anything new; all data will be collected from routine clinical care.
Conditions
- Overweight and Obesity
Sponsors & Collaborators
-
Aldafter Medical Center, Bahrain
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-25
- Primary Completion
- 2026-06-25
- Completion
- 2026-10-30
Countries
- Bahrain
Study Locations
More Related Trials
-
The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
NCT01719419 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Test Different Doses of BI 456906 in Patients With Obesity
NCT03591718 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
Weight Loss With Exenatide Treatment
NCT01590433 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity
NCT07400679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY
NCT04616339 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of ATL-962 in Obese Diabetics
NCT00156897 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
NCT06579092 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
NCT00109148 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
NCT01096979 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
NCT00677391 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers
NCT01372761 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
NCT01597609 ·Status: COMPLETED ·Phase: PHASE1
-
Lifestyle Modification and Liraglutide
NCT02911818 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiovascular System in Obesity: Effect of Treatment
NCT00000506 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
NCT01550926 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NGM395 in Adult Participants
NCT04187339 ·Status: COMPLETED ·Phase: PHASE1
-
Individualized Obesity Pharmacotherapy
NCT03374956 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
NCT00456885 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
NCT05369390 ·Status: COMPLETED ·Phase: PHASE1